Copyright
©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Aug 15, 2020; 11(8): 351-357
Published online Aug 15, 2020. doi: 10.4239/wjd.v11.i8.351
Published online Aug 15, 2020. doi: 10.4239/wjd.v11.i8.351
Interstitial lung disease and diabetes
Venkat Rajasurya, Department of Pulmonary and Critical Care, Novant Health System, Winston-Salem, NC 27103, United States
Kulothungan Gunasekaran, Department of Pulmonary and Critical Care, Yale-New Haven Health Bridgeport Hospital, CT 06610, United States
Salim Surani, Department of Pulmonary Critical Care and Sleep Medicine, Texas A&M Health Science Center, Bryan, TX 77807, United States
Author contributions: All authors have contributed to the preparation of manuscript, literature search and review of the manuscript.
Conflict-of-interest statement: The authors have no conflict of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Salim Surani, MD, MPH, NSHM, FACP, FCCP, Professor, Department of Pulmonary Critical Care and Sleep Medicine, Texas A&M Health Science Center, 8441 Riverside Pkwy, Bryan, TX 77807, United States. salim.surani@hcahealthcare.com
Received: March 15, 2020
Peer-review started: March 15, 2020
First decision: April 26, 2020
Revised: May 1, 2020
Accepted: July 26, 2020
Article in press: July 26, 2020
Published online: August 15, 2020
Peer-review started: March 15, 2020
First decision: April 26, 2020
Revised: May 1, 2020
Accepted: July 26, 2020
Article in press: July 26, 2020
Published online: August 15, 2020
Core Tip
Core tip: Diabetes mellitus is a common chronic disease with a high prevalence that leads to multiple complications and comorbidities. Diabetic lung or diabetic pneumopathy is a condition characterized by progressive lung disease caused by the microvascular complications associated with diabetes mellitus. Early recognition of this complication and strict blood sugar control in patients with diabetes can prevent the progression and debilitating symptoms associated with the diabetic lung.